Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in Canada in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
13 companies reporting in the next 90 days. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Wednesday, Sep 23 · in 27 days · 1 company | |||||
| INM | InMed Pharmaceuticals Inc. | Rare disease | $7.64M | −14.37% | |
| Tuesday, Nov 3 · in 68 days · 2 companies | |||||
| EPRX | Eupraxia Pharmaceuticals Inc. | Rare disease | $490.26M | +21.80% | |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | Rare disease | $487.17M | +20.23% | |
| Monday, Nov 9 · in 74 days · 1 company | |||||
| AUPH | Aurinia Pharmaceuticals Inc. | Rare disease | |||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| $2.20B |
| +10.56% |
| Wednesday, Nov 11 · in 76 days · 1 company | |||||
| MDP.TO | Medexus Pharmaceuticals Inc. | Rare disease | $117.29M | +7.02% | |
| Thursday, Nov 12 · in 77 days · 8 companies | |||||
| CRDL | Cardiol Therapeutics Inc. | Rare disease | $250.00M | +78.33% | |
| CRDL.TO | Cardiol Therapeutics Inc. | Rare disease | $249.99M | +74.71% | |
| MSCL.TO | Satellos Bioscience Inc. | Rare disease | $199.95M | −2.10% | |
| MSLE | Satellos Bioscience Inc. | Rare disease | $198.59M | −1.06% | |
| MIST | Milestone Pharmaceuticals Inc. | Rare disease | $146.91M | +10.28% | |
| RVX.TO | Resverlogix Corp. | Rare disease | $24.81M | 0.00% | |
| XRTX | XORTX Therapeutics Inc. | Rare disease | $4.03M | +8.20% | |
| APLI.TO | Appili Therapeutics Inc. | Rare disease | $1.44M | +50.00% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.